Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia. - Test2 - elhamkhani - TriplyDB

Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia.

Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia.

http://www.wikidata.org/entity/Q44383212

about

Ischemic stroke injury is mediated by aberrant Cdk5 A prolyl-isomerase mediates dopamine-dependent plasticity and cocaine motor sensitization Selective actions of novel allosteric modulators reveal functional heteromers of metabotropic glutamate receptors in the CNS Striatal overexpression of DeltaFosB reproduces chronic levodopa-induced involuntary movements Dopamine Replacement Therapy, Learning and Reward Prediction in Parkinson's Disease: Implications for Rehabilitation Striatal Plasticity in L-DOPA- and Graft-Induced Dyskinesia; The Common Link?Modeling intracellular signaling underlying striatal function in health and disease Pharmacological Treatments Inhibiting Levodopa-Induced Dyskinesias in MPTP-Lesioned Monkeys: Brain Glutamate Biochemical Correlates Levodopa-induced plasticity: a double-edged sword in Parkinson's disease?Synaptic dysfunction and septin protein family members in neurodegenerative diseases Signaling mechanisms and disrupted cytoskeleton in the diphenyl ditelluride neurotoxicity Dynamic rewiring of neural circuits in the motor cortex in mouse models of Parkinson's disease.Are cyclooxygenase-2 and nitric oxide involved in the dyskinesia of Parkinson's disease induced by L-DOPA?A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old mice Targeting β-arrestin2 in the treatment of L-DOPA-induced dyskinesia in Parkinson's disease.C. elegans dopaminergic D2-like receptors delimit recurrent cholinergic-mediated motor programs during a goal-oriented behavior Acupuncture enhances the synaptic dopamine availability to improve motor function in a mouse model of Parkinson's disease The internal state of medium spiny neurons varies in response to different input signals Review: Modulation of striatal neuron activity by cyclic nucleotide signaling and phosphodiesterase inhibition Adaptive gene regulation in the Striatum of RGS9-deficient mice A substrate trapping mutant form of striatal-enriched protein tyrosine phosphatase prevents amphetamine-induced stereotypies and long-term potentiation in the striatum Dopamine depletion alters phosphorylation of striatal proteins in a model of Parkinsonism PSD-95 expression controls L-DOPA dyskinesia through dopamine D1 receptor trafficking Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia A unified framework for addiction: vulnerabilities in the decision process Chronic 3,4-dihydroxyphenylalanine treatment induces dyskinesia in aphakia mice, a novel genetic model of Parkinson's disease.Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors.Cell type-specific plasticity of striatal projection neurons in parkinsonism and L-DOPA-induced dyskinesia.Rhes influences striatal cAMP/PKA-dependent signaling and synaptic plasticity in a gender-sensitive fashion.Brain morphometry and the neurobiology of levodopa-induced dyskinesias: current knowledge and future potential for translational pre-clinical neuroimaging studies.Chemogenetic stimulation of striatal projection neurons modulates responses to Parkinson's disease therapy.Dopamine in motor cortex is necessary for skill learning and synaptic plasticity.Distinct changes in cAMP and extracellular signal-regulated protein kinase signalling in L-DOPA-induced dyskinesia.Striatal proteomic analysis suggests that first L-dopa dose equates to chronic exposure.Pharmacological modulation of glutamate transmission in a rat model of L-DOPA-induced dyskinesia: effects on motor behavior and striatal nuclear signaling Spine Enlargement of Pyramidal Tract-Type Neurons in the Motor Cortex of a Rat Model of Levodopa-Induced Dyskinesia Cyclic AMP and afferent activity govern bidirectional synaptic plasticity in striatopallidal neurons.Presynaptic dopaminergic compartment determines the susceptibility to L-DOPA-induced dyskinesia in rats Involvement of the bed nucleus of the stria terminalis in L-Dopa induced dyskinesia In vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liability

P2860

Q23912228-8C3EAB35-C46D-4BD5-84B1-B089E900E025 Q24314505-7464C13D-2EA7-4692-B03C-74802FB353E8 Q24629746-07DAC113-5449-46AA-AD4E-30793C2C8C29 Q24632752-C09AF8B3-BEE1-4815-A571-06E4B4FDCF05 Q26744652-973A4890-5BD3-4946-843E-4E01E9EF5D24 Q26768220-3100F403-0ECF-4404-B721-5C184FEA8091 Q26851389-C9EFB8B1-1812-4187-91DC-789284432B33 Q26852311-E63C116D-F77C-45EC-85E4-DF5EA8E15336 Q27002626-1B8A6DE2-C3F9-473A-A9AA-636909BB5748 Q27026829-2B0DF0D3-FB4D-468B-A82B-2F6AFA084858 Q27026946-9677EEB8-BB71-4576-B654-610C6D2754EE Q27312058-CD2E0EBE-ADFA-43CB-8841-795BBFEE35C1 Q27324133-18E751AE-A389-40BF-AF29-BBA975E5E462 Q27324171-7FAA8848-3868-4195-98AD-ED05A5069B9A Q27324174-BE8B4711-F803-460E-8ABF-0D8C2336B8C0 Q27330422-74515AFD-0598-45FE-869F-A774D6667C70 Q28394023-59D5C2B3-22B5-43C7-B008-44FE30DC2B35 Q28394570-E15FCAE6-F249-4C38-A502-0E12F7732673 Q28394979-FCE4CBC8-396A-4635-9DD4-BF4F3EF878E1 Q28541409-A545A923-F2CA-4D9A-9C5B-774CF0AAF88A Q28573319-45B2461B-94F3-4822-BD24-F430BB5FB18B Q28579756-F0C54E29-DF4D-4077-89D1-DDDD9B1A1FC9 Q28582674-4EA07A68-14E2-46DB-9725-C18C260C10D9 Q28648007-B9046077-36DF-4D99-ABAA-256DF548CDE9 Q28680729-A491799F-66B5-4554-8788-343889F596B8 Q30484170-6BAE1F93-BF20-4089-9114-971EB45FEC83 Q30594829-844F943D-48F1-4146-AF2C-5A866FF6610E Q30650489-883DE913-964F-48A0-8E88-11C0517DB154 Q30658223-F086488C-7849-4EE5-A86C-D8778419B7F5 Q30833645-5EEC50C9-1B2A-4E68-AD38-A5C242054A26 Q30836713-FD442D4B-88DC-41CC-BB38-A8DD6FC51CCD Q30873734-44DAE2D5-8D95-410E-B040-26C7296386B9 Q30988635-A77E9D4E-D6D1-465E-991B-8DB42AE50B6F Q33319566-D557805B-A491-453F-92F7-B5867D413114 Q33428476-E60EE599-CB97-4940-9EAB-9FBCD9E4FB53 Q33559375-6DA8598D-1050-4C01-BAF1-81E4C57D1BDD Q33575226-A9154C89-BA77-4D08-BAD6-901CB4F2738E Q33628372-0DF2C74D-497E-403B-84B0-72D5D9F5A4F6 Q33725654-C0AAE4ED-A802-472C-9947-747180E96FB0 Q33751118-7E29C49A-88DB-413A-A20D-E7A99B9CD24A

P2860

Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia.

http://www.wikidata.org/entity/Q44383212

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia.

@en

Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia.

@nl

type

label

Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia.

@en

Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia.

@nl

prefLabel

Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia.

@en

Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia.

@nl

P1433

Q44383212-6A51DEF3-FCE7-40D8-832B-5A08754F437D

P1476

Q44383212-82B785AB-1805-4CDE-B6A5-BB63C36C0D28

P2093

Q44383212-266C5037-01F6-4F46-8E46-A0846BC9DEA8

Q44383212-6DFAE265-61C7-485E-9235-019BA447F374

Q44383212-A4C1E625-C581-4AAF-9BCC-78D924D84159

Q44383212-BB826ACC-2923-4AF5-91B1-B5717755650D

Q44383212-EBDA3F31-4BC0-4787-9161-A83E1EF92976

P2860

Q44383212-04D5154C-78F3-4976-853F-00BB80666562

Q44383212-162CF906-E0B7-4374-85FC-2AF3487624D0

Q44383212-35398A75-929E-47E9-BDE7-14330F2B7DDD

Q44383212-359B252A-A15A-4BF0-9188-6AC36664CD8A

Q44383212-43A61342-6F1A-401F-8CF5-371394410F2B

Q44383212-450913F4-657A-4E91-81B2-CB7520C0CEF5

Q44383212-45E07964-9AF0-414D-ADB6-FC0DDD75C8C1

Q44383212-4A1A16E8-244D-4239-89A0-ECFC7BE1674C

Q44383212-538ED934-2E0B-402F-9A5E-6934281955FE

Q44383212-61512B8A-E7FC-4FC9-A619-0DB640980E54

P2888

Q44383212-6ED36BF3-547C-4E9E-82E2-2120F1BD83D5

P304

Q44383212-4B2B09A3-81A2-4974-BE70-C99A22241AB4

P31

Q44383212-1758334F-5AFF-466E-B98D-6D56E0D85498

P356

Q44383212-EE50A754-45E1-45C1-8786-35006EEA5E04

P407

Q44383212-61059173-52BF-4C20-BC36-BD88F72C0C9D

P433

Q44383212-37DBAF95-AD59-46AE-B243-DA210F06602D

P478

Q44383212-31B3C474-2426-45F2-9877-60DBD8660733

P50

Q44383212-0AFD93CF-4386-4BD6-94C2-2E11C13837C2

Q44383212-5412FD18-34A8-4E19-AB33-014640EE0FD0

Q44383212-AD9186B7-D752-401D-B979-CFFB4032AB73

P577

Q44383212-0C0434FC-B5CE-4E75-BF3E-B737C400BACF

P5875

Q44383212-0D112CB4-0182-4CE1-9D04-82EF3D0102DE

P698

Q44383212-A74D45B2-7D25-43F1-8E4D-1208FAA1AA82

P921

Q44383212-4CB814C2-F17B-4F80-BDF0-66407650D190

Q44383212-F760C407-A4C0-4FD9-9863-58E7CD833F29

P356

P1433

Nature Neuroscience

P1476

Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia.

@en

P2093

Gilberto Fisone

http://www.w3.org/2001/XMLSchema#string

Giorgio Bernardi

http://www.w3.org/2001/XMLSchema#string

Kerstin Håkansson

http://www.w3.org/2001/XMLSchema#string

M Angela Cenci

http://www.w3.org/2001/XMLSchema#string

Paolo Calabresi

http://www.w3.org/2001/XMLSchema#string

P2860

DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1

Striatal fosB expression is causally linked with l-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease

Parkinson's disease. First of two parts

Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease.

Progress in understanding the factors regulating reversibility of long-term potentiation.

Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade.

Building action repertoires: memory and learning functions of the basal ganglia.

Levodopa motor complications in Parkinson's disease.

Electrophysiology of dopamine in normal and denervated striatal neurons.

Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism.

P2888

P304

501-506

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NN1040

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Barbara Picconi

P577

2003-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10830119

http://www.w3.org/2001/XMLSchema#string

P698

12665799

http://www.w3.org/2001/XMLSchema#string

P921

corpus striatum